Table 1.
Demographic characteristics, clinical and functional assessment by CMR
| Clinical phases | Total | p | |||
|---|---|---|---|---|---|
| Indeterminate | CPND | CPD | |||
| (n = 16) | (n = 17) | (n = 21) | (n = 54) | ||
| Age | 57.8 ± 11.9 | 54.3 ± 10.3 | 54.7 ± 11.3 | 55.5 ± 11.1 | 0.61 |
| Male | 3 (18.7 %) | 7 (41.1 %) | 16 (76.1 %) | 26 (48.1 %) | 0.02 |
| FC NYHA = I | 16 (100 %) | 14 (82.4 %) | 1 (4.8 %) | 31 (57.4 %) | <0.001 |
| FC NYHA > I | 0 (0) | 3 (17.6 %) | 20 (95.2 %) | 23 (42.6 %) | <0.001 |
| RVEDVi (ml/m2) | 67.7 ± 14.9 | 70.4 ± 12.2 | 78.0 ± 22.7 | 72.6 ± 18.0 | 0.19 |
| RVESVi (ml/m2) | 25.9a ± 5.6 | 32.0 ± 9.1 | 40.8a ± 21.7 | 33.6 ± 15.8 | 0.01 |
| RVEF (%) | 60.9a ± 7.1 | 54.7 ± 7.9 | 49.2a ± 12.8 | 54.4 ± 10.9 | 0.04 |
| LVEDVi (ml/m2) | 72.0a ± 15.4 | 84.6b ± 22.7 | 137.0a, b ± 44.0 | 101.4 ± 42.6 | <0.001 |
| LVESVi (ml/m2) | 24.9a ± 6.3 | 39.7b ± 19.5 | 90.4a, b ± 42.3 | 55.0 ± 40.6 | <0.001 |
| LVEF (%) | 65.0a ± 5.7 | 54.0a ± 12.0 | 35.8a ± 10.8 | 50.2 ± 15.8 | <0.001 |
| Mass index(g/m2) | 55.2a ± 10.5 | 70.9 ± 15.8 | 82.2a ± 27.6 | 70.6 ± 22.8 | 0.01 |
Data are expressed as mean ± SD for numeric variables or absolute and relative frequencies (%) for categorical variables
CPND cardiac phase without left ventricular systolic dysfunction, CPD cardiac phase with left ventricular systolic dysfunctional. LV left ventricle, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, RV right ventricle. FC functional class, NYHA New York Heart Association
Difference by post hoc analysis (a, b)